Sleep Apnea Tied to Higher Levels of Alzheimer's Biomarker in Brain

People suffering from sleep apnea may have higher accumulations of an Alzheimer’s disease biomarker called tau in an area of the brain that helps with memory, reveals a new study.

People suffering from sleep apnea may have higher levels of an Alzheimer’s disease biomarker in the brain, reports a new study.

People who are witnessed by a bed partner to have stopped breathing during sleep may have higher accumulations of an Alzheimer's disease biomarker called tau in an area of the brain that helps with memory, according to a preliminary study released that will be presented at the American Academy of Neurology's 71st Annual Meeting in Philadelphia.

Alzheimer’s disease - Causes, Symptoms, Diagnosis, Stages, Types, Prevention, Prognosis & Treatment
Alzheimer's disease is a progressive neurodegenerative disease affecting memory and thinking and making the person increasingly dependent on others.

‘People suffering from sleep apnea may have higher accumulations of an Alzheimer’s disease biomarker called tau in the brain.’
Read More..

Obstructive sleep apnea (OSA) is a condition that involves frequent events of stopped breathing during sleep, although an apnea may also be a single event of paused breathing during sleep.

Tau, a protein that forms into tangles, is found in the brains of people with Alzheimer's disease.

"A person normally has fewer than five episodes of apnea per hour during sleep," said study author Diego Z. Carvalho, MD, of the Mayo Clinic in Rochester, Minn., and a member of the American Academy of Neurology. "Bed partners are more likely to notice these episodes when people stop breathing several times per hour during sleep, raising concern for obstructive sleep apnea. Recent research has linked sleep apnea to an increased risk of dementia, so our study sought to investigate whether witnessed apneas during sleep may be linked to tau protein deposition in the brain."

Obstructive Sleep Apnea - Overview
Obstructive sleep apnea should be suspected in overweight middle aged adults who snore loudly and which can cause interruption of breathing for 10 seconds or more and this results in reduced blood o

The study involved 288 people age 65 and older who did not have cognitive impairment. Bed partners were asked whether they had witnessed episodes of stopped breathing during sleep.

Participants had positron emission tomography (PET) brain scans to look for accumulation of tau tangles in the entorhinal cortex area of the brain, an area of the brain in the temporal lobe that is more likely to accumulate tau than some other areas. This area of the brain helps manage memory, navigation, and perception of time.

Genetics of Alzheimer’s disease
There are numerous genes that have been discovered that are associated with Alzheimer’s disease and indicate increased risk, aiding genetic counseling and better care.

A team of researchers identified 43 participants, 15 percent of the study group, whose bed partners witnessed apneas when they were sleeping.

The research team found those who had apneas had on average 4.5 percent higher levels of tau in the entorhinal cortex than those who did not have apneas, after controlling for several other factors that could affect levels of tau in the brain, such as age, sex, education, cardiovascular risk factors and other sleep complaints.

Length of Breathing Disruption in Sleep Apnea May Help Predict Death Risk
The length of interrupted breathing in sleep apnea patients may be a better predictor of death risk. Men and women who have short apneas and hypopneas during sleep are at a higher risk of dying, reveals a new study.

"Our research results raise the possibility that sleep apnea affects tau accumulation," said Carvalho. "But it's also possible that higher levels of tau in other regions may predispose a person to sleep apnea, so longer studies are now needed to solve this chicken and egg problem."

Limitations of the study included its relatively small sample size and preliminary nature of the study requiring future validation. Furthermore, a lack of sleep studies to confirm the presence and severity of sleep apnea and a lack of information regarding whether or not participants were already receiving treatment for sleep apnea is another serious limitation.

Source-Eurekalert